参考文献/References:
[1] Sahin M, Demircioglu D,Oguz A,et al.Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?[J].Arch Endocrinol Metab,2017,61(2):145-151.DOI:10.1590/2359-3997000000225.
[2] Janssen OE, Mehlmauer N,Hahn S,et al.High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome[J].Eur J Endocrinol,2004,150(3):363-369.
[3] Calvar CE, Bengolea SV,Deutsch SI,et al.High frequency of thyroid abnormalities in polycystic ovary syndrome[J].Medicina(B Aires),2015,75(4):213-217.
[4] Al-Saab R, Haddad S.Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome:a case-control study from Syria[J].Int J Endocrinol Metab,2014,12(3):e17954. DOI:10.5812/ijem.17954.
[5] Nisar S,Shah PA,Kuchay MS,et al.Association of polycystic ovary syndrome and Graves' disease: is autoimmunity the link between the two diseases [J].Indian J Endocrinol Metab,2012,16(6):982-986. DOI:10.4103/2230-8210.103006.
[6] Zaletel K,Gabersˇcˇek S.Hashimoto's thyroiditis: from genes to the disease[J].Curr Genomics,2011,12(8):576-588.DOI:10.2174/138920211798120763.
[7] Dong YH,Fu DG.Autoimmune thyroid disease: mechanism, genetics and current knowledge[J].Eur Rev Med Pharmacol Sci,2014,18(23):3611-3618.
[8] Raja-Khan N,Urbanek M,Rodgers RJ,et al. The role of TGF-β in polycystic ovary syndrome[J].Reprod Sci,2014,21(1):20-31.DOI:10.1177/1933719113485294.
[9] Kowalczyk K, Franik G, Kowalczyk D,et al. Thyroid disorders in polycystic ovary syndrome[J].Eur Rev Med Pharmacol Sci,2017,21(2):346-360.
[10] Mariotti S,Prinzis A,Ghiani M,et al.Puberty is associated with a marked increase of the female sex predominance in chronic autoimmune thyroiditis[J].Horm Res,2009,72(1):52-56. DOI:10.1159/000224341.
[11] Quintero OL,Amador-Patarroyo MJ,Montoya-Ortiz G,et al.Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity[J].J Autoimmun,2012,38(2-3):J109-J119. DOI:10.1016/j.jaut.2011.10.003.
[12] Kosova G,Urbanek M.Genetics of the polycystic ovary syndrome[J].Mol Cell Endocrinol,2013,373(1-2):29-38.DOI:10.1016/j.mce.2012.10.009.
[13] Pludowski P,Holick MF,Pilz S,et al.Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence[J].Autoimmun Rev,2013,12(10):976-989. DOI:10.1016/j.autrev.2013.02.004.
[14] Arduc A,Aycicek Dogan B,Bilmez S,et al.High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?[J].Endocr Res,2015,40(4):204-210. DOI:10.3109/07435800.2015.1015730.
[15] Choi YM,Kim WG,Kim TY,et al.Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women[J].Thyroid,2014,24(4):655-661.DOI:10.1089/thy.2013.0460.
[16] Kim D.Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis[J].Hormones(Athens),2016,15(3):385-393.DOI:10.14310/horm.2002.1681.
[17] Lazúrová I, Figurová J, Dravecká I. Vitamin D and polycystic ovary syndrome[J].Vnitr Lek,2016,62(9 Suppl 3):87-91.
[18] Karada C,Yoldemir T,Yavuz DG.Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients[J].J Obstet Gynaecol Res,2018,44(2):270-277.DOI:10.1111/jog.13516.
[19] Karaköse M, Hepsen S, Çakal E, et al.Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome[J].J Turk Ger Gynecol Assoc,2017,18(2):85-89.DOI:10.4274/jtgga.2016.0217.
[20] Yasar HY,Ertugˇrul O,Ertugˇrul B,et al.Insulin resistance in nodular thyroid disease[J].Endocr Res,2011,36(4):167-174.DOI:10.3109/07435800.2011.593011.
[21] Aghajanova L, Lindeberg M, Carlsson IB,et al.Receptors for thyroid-stimulating hormone and thyroid hormones in human ovariantissue[J].Reprod Biomed Online,2009,18(3):337-347.
[22] Costa NN, Cordeiro MS,Silva TV, et al.Effect of triiodothyronine on developmental competence of bovine oocytes[J].Theriogenology,2013,80(4):295-301. DOI:10.1016/j.theriogenology.2013.04.011.
[23] Rotondi M,Cappelli C,Magri F,et al.Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome[J].Clin Endocrinol(Oxf),2011,75(3):378-381. DOI:10.1111/j.1365-2265.2011.04042.x.
[24] Krysiak R, Szkróbka W,Okopień B. Sex-dependent effect of metformin on hypothalamic-pituitary-thyroid axis activity in patients with subclinical hypothyroidism[J].Pharmacol Rep,2016,68(6):1115-1119. DOI:10.1016/j.pharep.2016.07.002.
[25] Krysiak R,Okopien B.The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism[J].J Clin Pharmacol,2015,55(1):45-49.DOI:10.1002/jcph.373.
[26] Abdulrahman RM, Boon MR, Sips HC,et al. Impact of metformin and compound C on NIS expression and iodine uptake in vitro and in vivo: a role for CRE in AMPK modulation of thyroid function[J].Thyroid,2014,24(1):78-87.DOI:10.1089/thy.2013.0041.
[27] Yin D, Ruan X, Tian X, et al.The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome[J].Gynecol Endocrinol,2017,33(4):332-335.DOI:10.1080/09513590.2016.1273895.
[28] Muderris II, Boztosun A,Oner G,et al.Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism[J].Ann Saudi Med,2011,31(2):145-151.DOI:10.4103/0256-4947.77500.
相似文献/References:
[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(03):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]杨健姝,华飞,唐暎,等.二甲双胍在多囊卵巢综合征患者妊娠期的应用[J].国际内分泌代谢杂志,2014,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
Yang Jianshu,Hua Fei,Tang Ying,et al.The application of metformin in the pregnant patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
[3]朱丹,陈国芳,刘超,等.糖尿病患者合并甲状腺功能异常的机制
及其影响[J].国际内分泌代谢杂志,2016,36(03):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
Zhu Dan*,Chen Guofang,Liu Chao,et al.Mechanisms of diabetes combined with thyroid dysfunction and its influence[J].International Journal of Endocrinology and Metabolism,2016,36(03):206.[doi:10.3760/cma.j.issn.1673-4157.2016.03.16]
[4]房方,卫红艳,王坤玲,等.硒治疗自身免疫性甲状腺疾病的荟萃分析[J].国际内分泌代谢杂志,2016,36(04):247.[doi:10.3760/cma.j.issn.1673-4157.2016.04.09]
Fang Fang,Wei Hongyan,Wang Kunling,et al.A meta-analysis of selenium in the treatment of autoimmune thyroid diseases[J].International Journal of Endocrinology and Metabolism,2016,36(03):247.[doi:10.3760/cma.j.issn.1673-4157.2016.04.09]
[5]郑慧娟,魏璠,魏军平.自噬与自身免疫性甲状腺疾病[J].国际内分泌代谢杂志,2017,37(01):17.[doi:10.3760/cma.j.issn.1673-4157.2017.01.05]
Zheng Huijuan,Wei Fan,Wei Junping..Autophagy and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2017,37(03):17.[doi:10.3760/cma.j.issn.1673-4157.2017.01.05]
[6]乔冠华,李强.胰高血糖素样肽-1受体激动剂治疗多囊卵巢综合征的研究进展[J].国际内分泌代谢杂志,2017,37(03):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
Qiao Guanhua,Li Qiang..Glucagon like peptide-1 receptor agonist in the treatment of polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(03):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
[7]廖鑫 张开羽 高琳 张晗 张琳 邓凡曲 黄琦 李思成 张凌.多囊卵巢综合征患者血清PTX3、vaspin
水平的观察研究[J].国际内分泌代谢杂志,2018,38(04):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
Liao Xin*,Zhang Kaiyu,Gao Lin,et al.Study of serum PTX3 and vaspin levels in patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(03):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
[8]相萍萍 刘超.滤泡辅助性T细胞、滤泡调节性T细胞与自身免疫性
甲状腺疾病[J].国际内分泌代谢杂志,2019,39(03):168.[doi:10.3760/cma.j.issn.1673-4157.2019.03.006]
Xiang Pingping,Liu Chao.T foliicular helper cells, T follicular regulatory cells and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2019,39(03):168.[doi:10.3760/cma.j.issn.1673-4157.2019.03.006]
[9]袁铖 华飞.Th1/Th2失衡与多囊卵巢综合征[J].国际内分泌代谢杂志,2020,40(01):59.[doi:10.3760/cma.j.issn.1673-4157.2020.01.014]
Yuan Cheng,Hua Fei.Th1/Th2 imbalance and polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2020,40(03):59.[doi:10.3760/cma.j.issn.1673-4157.2020.01.014]
[10]杨小颖 唐露霖 尚文斌.表观遗传修饰在自身免疫性甲状腺疾病发病中的作用[J].国际内分泌代谢杂志,2020,40(03):169.[doi:10.3760/cma.j.issn.1673-4157.2020.03.006]
Yang Xiao-ying,Tang Lulin,Shang Wenbin.The role of epigenetic modification in the pathogenesis of autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2020,40(03):169.[doi:10.3760/cma.j.issn.1673-4157.2020.03.006]
[11]梁杏燕,赵捷,马红霞.自身免疫性甲状腺疾病对多囊卵巢综合征不良妊娠结局的影响[J].国际内分泌代谢杂志,2022,42(06):481.[doi:10.3760/cma.j.cn121383-20211016-10036]
Liang Xingyan,Zhao Jie,Ma Hongxia..Influence of autoimmune thyroid disease on adverse pregnant outcome in polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2022,42(03):481.[doi:10.3760/cma.j.cn121383-20211016-10036]